406 related articles for article (PubMed ID: 25256353)
21. Nuclear import impairment causes cytoplasmic trans-activation response DNA-binding protein accumulation and is associated with frontotemporal lobar degeneration.
Nishimura AL; Zupunski V; Troakes C; Kathe C; Fratta P; Howell M; Gallo JM; Hortobágyi T; Shaw CE; Rogelj B
Brain; 2010 Jun; 133(Pt 6):1763-71. PubMed ID: 20472655
[TBL] [Abstract][Full Text] [Related]
22. Functional recovery in new mouse models of ALS/FTLD after clearance of pathological cytoplasmic TDP-43.
Walker AK; Spiller KJ; Ge G; Zheng A; Xu Y; Zhou M; Tripathy K; Kwong LK; Trojanowski JQ; Lee VM
Acta Neuropathol; 2015 Nov; 130(5):643-60. PubMed ID: 26197969
[TBL] [Abstract][Full Text] [Related]
23. GPNMB ameliorates mutant TDP-43-induced motor neuron cell death.
Nagahara Y; Shimazawa M; Ohuchi K; Ito J; Takahashi H; Tsuruma K; Kakita A; Hara H
J Neurosci Res; 2017 Aug; 95(8):1647-1665. PubMed ID: 27935101
[TBL] [Abstract][Full Text] [Related]
24. Targeted depletion of TDP-43 expression in the spinal cord motor neurons leads to the development of amyotrophic lateral sclerosis-like phenotypes in mice.
Wu LS; Cheng WC; Shen CK
J Biol Chem; 2012 Aug; 287(33):27335-44. PubMed ID: 22718760
[TBL] [Abstract][Full Text] [Related]
25. TDP-43 pathology in sporadic ALS occurs in motor neurons lacking the RNA editing enzyme ADAR2.
Aizawa H; Sawada J; Hideyama T; Yamashita T; Katayama T; Hasebe N; Kimura T; Yahara O; Kwak S
Acta Neuropathol; 2010 Jul; 120(1):75-84. PubMed ID: 20372915
[TBL] [Abstract][Full Text] [Related]
26. The ALS disease protein TDP-43 is actively transported in motor neuron axons and regulates axon outgrowth.
Fallini C; Bassell GJ; Rossoll W
Hum Mol Genet; 2012 Aug; 21(16):3703-18. PubMed ID: 22641816
[TBL] [Abstract][Full Text] [Related]
27. AMPK Signalling and Defective Energy Metabolism in Amyotrophic Lateral Sclerosis.
Perera ND; Turner BJ
Neurochem Res; 2016 Mar; 41(3):544-53. PubMed ID: 26202426
[TBL] [Abstract][Full Text] [Related]
28. Motor neuron translatome reveals deregulation of SYNGR4 and PLEKHB1 in mutant TDP-43 amyotrophic lateral sclerosis models.
Marques RF; Engler JB; Küchler K; Jones RA; Lingner T; Salinas G; Gillingwater TH; Friese MA; Duncan KE
Hum Mol Genet; 2020 Sep; 29(16):2647-2661. PubMed ID: 32686835
[TBL] [Abstract][Full Text] [Related]
29. Withania somnifera Reverses Transactive Response DNA Binding Protein 43 Proteinopathy in a Mouse Model of Amyotrophic Lateral Sclerosis/Frontotemporal Lobar Degeneration.
Dutta K; Patel P; Rahimian R; Phaneuf D; Julien JP
Neurotherapeutics; 2017 Apr; 14(2):447-462. PubMed ID: 27928708
[TBL] [Abstract][Full Text] [Related]
30. Enhancing survival motor neuron expression extends lifespan and attenuates neurodegeneration in mutant TDP-43 mice.
Perera ND; Sheean RK; Crouch PJ; White AR; Horne MK; Turner BJ
Hum Mol Genet; 2016 Sep; 25(18):4080-4093. PubMed ID: 27466204
[TBL] [Abstract][Full Text] [Related]
31. Rab1-dependent ER-Golgi transport dysfunction is a common pathogenic mechanism in SOD1, TDP-43 and FUS-associated ALS.
Soo KY; Halloran M; Sundaramoorthy V; Parakh S; Toth RP; Southam KA; McLean CA; Lock P; King A; Farg MA; Atkin JD
Acta Neuropathol; 2015 Nov; 130(5):679-97. PubMed ID: 26298469
[TBL] [Abstract][Full Text] [Related]
32. Wild type human TDP-43 potentiates ALS-linked mutant TDP-43 driven progressive motor and cortical neuron degeneration with pathological features of ALS.
Mitchell JC; Constable R; So E; Vance C; Scotter E; Glover L; Hortobagyi T; Arnold ES; Ling SC; McAlonis M; Da Cruz S; Polymenidou M; Tessarolo L; Cleveland DW; Shaw CE
Acta Neuropathol Commun; 2015 Jun; 3():36. PubMed ID: 26108367
[TBL] [Abstract][Full Text] [Related]
33. Quantification of the Relative Contributions of Loss-of-function and Gain-of-function Mechanisms in TAR DNA-binding Protein 43 (TDP-43) Proteinopathies.
Cascella R; Capitini C; Fani G; Dobson CM; Cecchi C; Chiti F
J Biol Chem; 2016 Sep; 291(37):19437-48. PubMed ID: 27445339
[TBL] [Abstract][Full Text] [Related]
34. The D2 Dopamine Receptor Interferes With the Protective Effect of the A
Lai CY; Liu YJ; Lai HL; Chen HM; Kuo HC; Liao YP; Chern Y
Front Neurosci; 2018; 12():187. PubMed ID: 29615863
[TBL] [Abstract][Full Text] [Related]
35. ALS-implicated protein TDP-43 sustains levels of STMN2, a mediator of motor neuron growth and repair.
Klim JR; Williams LA; Limone F; Guerra San Juan I; Davis-Dusenbery BN; Mordes DA; Burberry A; Steinbaugh MJ; Gamage KK; Kirchner R; Moccia R; Cassel SH; Chen K; Wainger BJ; Woolf CJ; Eggan K
Nat Neurosci; 2019 Feb; 22(2):167-179. PubMed ID: 30643292
[TBL] [Abstract][Full Text] [Related]
36. TDP-43 mutations causing amyotrophic lateral sclerosis are associated with altered expression of RNA-binding protein hnRNP K and affect the Nrf2 antioxidant pathway.
Moujalled D; Grubman A; Acevedo K; Yang S; Ke YD; Moujalled DM; Duncan C; Caragounis A; Perera ND; Turner BJ; Prudencio M; Petrucelli L; Blair I; Ittner LM; Crouch PJ; Liddell JR; White AR
Hum Mol Genet; 2017 May; 26(9):1732-1746. PubMed ID: 28334913
[TBL] [Abstract][Full Text] [Related]
37. Tar DNA binding protein of 43 kDa (TDP-43), 14-3-3 proteins and copper/zinc superoxide dismutase (SOD1) interact to modulate NFL mRNA stability. Implications for altered RNA processing in amyotrophic lateral sclerosis (ALS).
Volkening K; Leystra-Lantz C; Yang W; Jaffee H; Strong MJ
Brain Res; 2009 Dec; 1305():168-82. PubMed ID: 19815002
[TBL] [Abstract][Full Text] [Related]
38. ALS-associated TDP-43 induces endoplasmic reticulum stress, which drives cytoplasmic TDP-43 accumulation and stress granule formation.
Walker AK; Soo KY; Sundaramoorthy V; Parakh S; Ma Y; Farg MA; Wallace RH; Crouch PJ; Turner BJ; Horne MK; Atkin JD
PLoS One; 2013; 8(11):e81170. PubMed ID: 24312274
[TBL] [Abstract][Full Text] [Related]
39. Aberrant distributions of nuclear pore complex proteins in ALS mice and ALS patients.
Shang J; Yamashita T; Nakano Y; Morihara R; Li X; Feng T; Liu X; Huang Y; Fukui Y; Hishikawa N; Ohta Y; Abe K
Neuroscience; 2017 May; 350():158-168. PubMed ID: 28344074
[TBL] [Abstract][Full Text] [Related]
40. Amyotrophic lateral sclerosis mutant vesicle-associated membrane protein-associated protein-B transgenic mice develop TAR-DNA-binding protein-43 pathology.
Tudor EL; Galtrey CM; Perkinton MS; Lau KF; De Vos KJ; Mitchell JC; Ackerley S; Hortobágyi T; Vámos E; Leigh PN; Klasen C; McLoughlin DM; Shaw CE; Miller CC
Neuroscience; 2010 May; 167(3):774-85. PubMed ID: 20188146
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]